You are here: All Products  > AnHeart Says ROS1 Inhibitor Effective for NSCLC in Phase II Trial

AnHeart Says ROS1 Inhibitor Effective for NSCLC in Phase II Trial

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products